N-acetyl-seryl-aspartyl-lysyl-proline: A valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes

N-acetyl-seryl-aspartyl-lysyl-proline: A valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes

Fibroproliferative diseases are responsible for 45% of deaths in the developed world. Curing organ fibrosis is essential for fibroproliferative diseases. Diabetic nephropathy is a common fibroproliferative disease of the kidney and is associated with multiorgan dysfunction. However, therapy to comba...

Full description

Bibliographic Details
Main Authors: Keizo eKanasaki, Takako eNagai, Kyoko eNitta, Munehiro eKitada, Daisuke eKoya
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-04-01
Series:Frontiers in Pharmacology
Subjects:
Diabetes Mellitus
arb
fibroblast
kidney fibrosis
ACE-I
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00070/full

Similar Items

Similar Items